Pulmonology
<ѻýҕl class="page-description">News, opinions and meeting coverage in pulmonology.— Also in TTHealthWatch: time from approval to reimbursement for new drugs
Latest in Pulmonology
Other studies looked at steroids for kids with pneumonia and a link between asthma and fertility
One negative trial in the phase III PROMIS program blamed squarely on the COVID-19 pandemic
"We should be cautious about using drugs off-label," investigator says
One negative trial in the phase III PROMIS program blamed squarely on the COVID-19 pandemic
"We should be cautious about using drugs off-label," investigator says
Pulmonology Case Studies
Home test showed 52 apnea-hypopnea events per hour in woman with high blood pressure, weight gain
Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers
Clue from a previous diagnosis of another disease?
More in Pulmonology
Signal has generally trailed off, but more sensitive method showed virus lingering in Texas
Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan
Lawmakers also queried officials about a menthol cigarette rule and labeling of milk alternatives
However, plinabulin plus docetaxel still "not ready for prime time," expert says
They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
Absolute improvement of almost 30%, doubling of duration of response with savolitinib
Human-to-human transmission a key concern
Investigational depemokimab succeeds in patients with high blood eosinophil count
Two-trial analysis shows about a 40% decreased risk of disease recurrence or death
Novel agent nearly halved risk of progression as first-line therapy in phase III trial
Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy
An immediate appointment to a smoking cessation clinic shows benefit versus usual care
Risk to general public remains low, CDC says
Paul Offit, MD, talks about the flu, RSV, and COVID vaccines for the 2024-2025 season
